With more than $80 million in hand, the University of Texas MD Anderson Cancer Center has launched its own cell therapy ...

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

A St. Louis-based clinical-stage biotechnology company developing cancer-fighting drugs ... Wugen is developing "off the ...

Model used to create a cellular 'hologram' of a mouse embryo could be used to visualize development in any species.

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

Scientists have successfully immortalized lip cells, creating a clinically relevant lab model that enables testing of new ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have made a major discovery in how human ...

Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, ...

Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical ...